BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Orchard TR, Wordsworth BP, Jewell DP. Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history. Gut 1998;42:387-91. [PMID: 9577346 DOI: 10.1136/gut.42.3.387] [Cited by in Crossref: 347] [Cited by in F6Publishing: 252] [Article Influence: 14.5] [Reference Citation Analysis]
Number Citing Articles
1 Brühl J, Schirren M, Wei C, Antoni C, Böcker U. Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn’s disease: correlation of transient elastography and laboratory-based markers. European Journal of Gastroenterology & Hepatology 2011;23:923-30. [DOI: 10.1097/meg.0b013e3283499252] [Cited by in Crossref: 6] [Article Influence: 0.5] [Reference Citation Analysis]
2 Ouldali N, Hugot JP, Viala J, Damir M, Martinez-Vinson C, Meinzer U. Early Arthritis Is Associated With Failure of Immunosuppressive Drugs and Severe Pediatric Crohn's Disease Evolution. Inflamm Bowel Dis 2018;24:2423-30. [PMID: 29788152 DOI: 10.1093/ibd/izy137] [Reference Citation Analysis]
3 Hotta M, Minamimoto R, Kaneko H, Yamashita H. Fluorodeoxyglucose PET/CT of Arthritis in Rheumatic Diseases: A Pictorial Review. Radiographics. 2020;40:223-240. [PMID: 31917663 DOI: 10.1148/rg.2020190047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
4 Lakatos L, Pandur T, David G, Balogh Z, Kuronya P, Tollas A, Lakatos PL. Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: Results of a 25-year follow-up study. World J Gastroenterol 2003; 9(10): 2300-2307 [PMID: 14562397 DOI: 10.3748/wjg.v9.i10.2300] [Cited by in CrossRef: 173] [Cited by in F6Publishing: 160] [Article Influence: 9.1] [Reference Citation Analysis]
5 Yüksel I, Ataseven H, Başar O, Köklü S, Ertuğrul I, Ulker A, Dağlı U, Saşmaz N. Peripheral arthritis in the course of inflammatory bowel diseases. Dig Dis Sci 2011;56:183-7. [PMID: 20458624 DOI: 10.1007/s10620-010-1260-z] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
6 Orchard TR, Thiyagaraja S, Welsh KI, Wordsworth BP, Hill Gaston JS, Jewell DP. Clinical phenotype is related to HLA genotype in the peripheral arthropathies of inflammatory bowel disease. Gastroenterology. 2000;118:274-278. [PMID: 10648455 DOI: 10.1016/s0016-5085(00)70209-5] [Cited by in Crossref: 177] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
7 Arukha AP, Freguia CF, Mishra M, Jha JK, Kariyawasam S, Fanger NA, Zimmermann EM, Fanger GR, Sahay B. Lactococcus lactis Delivery of Surface Layer Protein A Protects Mice from Colitis by Re-Setting Host Immune Repertoire. Biomedicines 2021;9:1098. [PMID: 34572293 DOI: 10.3390/biomedicines9091098] [Reference Citation Analysis]
8 Vermeire S, Rutgeerts P. Current status of genetics research in inflammatory bowel disease. Genes Immun. 2005;6:637-645. [PMID: 16107869 DOI: 10.1038/sj.gene.6364257] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 4.2] [Reference Citation Analysis]
9 Stolwijk C, Pierik M, Landewé R, Masclee A, van Tubergen A. Prevalence of self-reported spondyloarthritis features in a cohort of patients with inflammatory bowel disease. Can J Gastroenterol 2013;27:199-205. [PMID: 23616957 DOI: 10.1155/2013/139702] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.9] [Reference Citation Analysis]
10 Wendling D, Prati C. Spondyloarthritis: Harlequin or Chameleon? J Rheumatol 2017;44:1293-4. [DOI: 10.3899/jrheum.170452] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
11 Al-jarallah K, Shehab D, Al-attiyah R, Al-azmi W, Al-fadli A, Zafar Haider M, Panaccione R, Ghosh S. Antibodies to mutated citrullinated vimentin and anti-cyclic citrullinated peptide antibodies in inflammatory bowel disease and related arthritis: . Inflammatory Bowel Diseases 2012;18:1655-62. [DOI: 10.1002/ibd.21937] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
12 Salvarani C, Fries W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol 2009; 15(20): 2449-2455 [PMID: 19468993 DOI: 10.3748/wjg.15.2449] [Cited by in CrossRef: 70] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
13 Speca S, Dubuquoy L. Chronic bowel inflammation and inflammatory joint disease: Pathophysiology. Joint Bone Spine 2017;84:417-20. [PMID: 28062378 DOI: 10.1016/j.jbspin.2016.12.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
14 Ng J, Zezoff D, Dargham HA. Leukocytoclastic Vasculitis as a Rare Dermatologic Extraintestinal Manifestation of Ulcerative Colitis in an Elderly Patient with Positive PR3-ANCA. Case Rep Gastrointest Med 2021;2021:5767699. [PMID: 34603802 DOI: 10.1155/2021/5767699] [Reference Citation Analysis]
15 Smale S, Tibble J, Sigthorsson G, Bjarnason I. Epidemiology and differential diagnosis of NSAID-induced injury to the mucosa of the small intestine. Best Pract Res Clin Gastroenterol. 2001;15:723-738. [PMID: 11566037 DOI: 10.1053/bega.2001.0231] [Cited by in Crossref: 54] [Cited by in F6Publishing: 42] [Article Influence: 2.6] [Reference Citation Analysis]
16 van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, Beaugerie L, Gomollón F, Häuser W, Herrlinger K, Oldenburg B, Panes J, Portela F, Rogler G, Stein J, Tilg H, Travis S, Lindsay JO. [Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations (Spanish version)]. Rev Gastroenterol Mex 2015;80:74-106. [PMID: 25769216 DOI: 10.1016/j.rgmx.2014.10.008] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Becker H, Gaubitz M, Domschke W, Kucharzik T. Treatment of arthralgias and spondyloarthropathy associated with inflammatory bowel disease. Future Rheumatology 2007;2:423-31. [DOI: 10.2217/17460816.2.4.423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
18 Orchard T. Extraintestinal complications of inflammatory bowel disease. Curr Gastroenterol Rep. 2003;5:512-517. [PMID: 14602062 DOI: 10.1007/s11894-003-0042-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 2.0] [Reference Citation Analysis]
19 Ossum AM, Palm Ø, Cvancarova M, Solberg IC, Vatn M, Moum B, Høivik ML; the IBSEN study group. Peripheral arthritis in patients with long-term inflammatory bowel disease. Results from 20 years of follow-up in the IBSEN study. Scandinavian Journal of Gastroenterology 2018;53:1250-6. [DOI: 10.1080/00365521.2018.1518482] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
20 Fatemi A, Jazi HH, Emami MH, Kazemizadeh A, Tavakkoli H, Smiley A. Relationship between articular and nonarticular manifestations in inflammatory bowel diseases. J Res Med Sci 2016;21:48. [PMID: 27904594 DOI: 10.4103/1735-1995.183989] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
21 Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs. 2012;72:2333-2349. [PMID: 23181971 DOI: 10.2165/11638120-000000000-00000] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
22 Sekhri S, Rao B, Mohananey A, Beniwal-Patel P, Bruss A, Stein DJ, Yarur AJ. Serum trough levels of infliximab are not associated with peripheral arthralgia activity in patients with inflammatory bowel disease. BMJ Open Gastroenterol 2021;8:e000788. [PMID: 34764142 DOI: 10.1136/bmjgast-2021-000788] [Reference Citation Analysis]
23 Martínez-Borra J, López-Larrea C, González S, Fuentes D, Dieguez A, Deschamps EM, Pérez-Pariente JM, López-Vázquez A, de Francisco R, Rodrigo L. High serum tumor necrosis factor-alpha levels are associated with lack of response to infliximab in fistulizing Crohn's disease. Am J Gastroenterol 2002;97:2350-6. [PMID: 12358255 DOI: 10.1111/j.1572-0241.2002.05990.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 23] [Article Influence: 0.7] [Reference Citation Analysis]
24 Peluso R, Manguso F, Vitiello M, Iervolino S, Di Minno MN. Management of arthropathy in inflammatory bowel diseases. Ther Adv Chronic Dis. 2015;6:65-77. [PMID: 25729557 DOI: 10.1177/2040622314563929] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
25 Kelly A, Tymms K, Tunnicliffe DJ, Sumpton D, Perera C, Fallon K, Craig JC, Abhayaratna W, Tong A. Patients' Attitudes and Experiences of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis and Spondyloarthritis: A Qualitative Synthesis. Arthritis Care Res (Hoboken) 2018;70:525-32. [PMID: 28732151 DOI: 10.1002/acr.23329] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
26 Van Assche G, Dignass A, Bokemeyer B, Danese S, Gionchetti P, Moser G, Beaugerie L, Gomollón F, Häuser W, Herrlinger K, Oldenburg B, Panes J, Portela F, Rogler G, Stein J, Tilg H, Travis S, Lindsay JO. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations. Journal of Crohn's and Colitis 2013;7:1-33. [DOI: 10.1016/j.crohns.2012.09.005] [Cited by in Crossref: 332] [Cited by in F6Publishing: 270] [Article Influence: 36.9] [Reference Citation Analysis]
27 Bernardi D, Podswiadek M, Zaninotto M, Punzi L, Plebani M. YKL-40 as a marker of joint involvement in inflammatory bowel disease. Clin Chem. 2003;49:1685-1688. [PMID: 14500601 DOI: 10.1373/49.10.1685] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
28 Picchianti-Diamanti A, Lorenzetti R, Chimenti MS, Luchetti MM, Conigliaro P, Canofari C, Benfaremo D, Bruzzese V, Laganà B, Perricone R; SIGR. Enteropathic spondyloarthritis: Results from a large nationwide database analysis. Autoimmun Rev 2020;19:102457. [PMID: 31838160 DOI: 10.1016/j.autrev.2019.102457] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
29 Armuzzi A, Felice C, Lubrano E, Cantini F, Castiglione F, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Marchesoni A, Vecchi M, Olivieri I. Multidisciplinary management of patients with coexisting inflammatory bowel disease and spondyloarthritis: A Delphi consensus among Italian experts. Digestive and Liver Disease 2017;49:1298-305. [DOI: 10.1016/j.dld.2017.06.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
30 Taddio A, Simonini G, Lionetti P, Lepore L, Martelossi S, Ventura A, Cimaz R. Usefulness of wireless capsule endoscopy for detecting inflammatory bowel disease in children presenting with arthropathy. Eur J Pediatr. 2011;170:1343-1347. [PMID: 21643650 DOI: 10.1007/s00431-011-1505-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
31 Hundorfean G, Neurath MF, Sitaru C. Autoimmunity against type VII collagen in inflammatory bowel disease. J Cell Mol Med 2010;14:2393-403. [PMID: 19878366 DOI: 10.1111/j.1582-4934.2009.00959.x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
32 Felice C, Leccese P, Scudeller L, Lubrano E, Cantini F, Castiglione F, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Vecchi M, Olivieri I, Armuzzi A; Italian SpA-IBD Expert Panel Group. Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis. Clin Exp Immunol 2019;196:123-38. [PMID: 30554407 DOI: 10.1111/cei.13246] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 van der Valk ME, Mangen MJ, Leenders M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, Pierik M, van der Woude CJ, Romberg-Camps MJ. Risk factors of work disability in patients with inflammatory bowel disease--a Dutch nationwide web-based survey: work disability in inflammatory bowel disease. J Crohns Colitis. 2014;8:590-597. [PMID: 24351733 DOI: 10.1016/j.crohns.2013.11.019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 4.2] [Reference Citation Analysis]
34 Sieper J, van der Heijde D. Review: Nonradiographic axial spondyloarthritis: new definition of an old disease? Arthritis Rheum. 2013;65:543-551. [PMID: 23233285 DOI: 10.1002/art.37803] [Cited by in Crossref: 118] [Cited by in F6Publishing: 93] [Article Influence: 13.1] [Reference Citation Analysis]
35 Hedin CRH, Vavricka SR, Stagg AJ, Schoepfer A, Raine T, Puig L, Pleyer U, Navarini A, van der Meulen-de Jong AE, Maul J, Katsanos K, Kagramanova A, Greuter T, González-Lama Y, van Gaalen F, Ellul P, Burisch J, Bettenworth D, Becker MD, Bamias G, Rieder F. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy. J Crohns Colitis 2019;13:541-54. [PMID: 30445584 DOI: 10.1093/ecco-jcc/jjy191] [Cited by in Crossref: 33] [Cited by in F6Publishing: 26] [Article Influence: 16.5] [Reference Citation Analysis]
36 Hanzel J, Ma C, Casteele NV, Khanna R, Jairath V, Feagan BG. Vedolizumab and Extraintestinal Manifestations in Inflammatory Bowel Disease. Drugs 2021;81:333-47. [PMID: 33400241 DOI: 10.1007/s40265-020-01460-3] [Reference Citation Analysis]
37 Siemanowski B, Regueiro M. Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease. Curr Treat Options Gastroenterol. 2007;10:178-184. [PMID: 17547856 DOI: 10.1007/s11938-007-0011-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
38 Büning C, Genschel J, Bühner S, Krüger S, Kling K, Dignass A, Baier P, Bochow B, Ockenga J, Schmidt HH. Mutations in the NOD2/CARD15 gene in Crohn’s disease are associated with ileocecal resection and are a risk factor for reoperation. Aliment Pharmacol Ther. 2004;19:1073-1078. [PMID: 15142196 DOI: 10.1111/j.1365-2036.2004.01967.x] [Cited by in Crossref: 86] [Cited by in F6Publishing: 90] [Article Influence: 4.8] [Reference Citation Analysis]
39 Paine A, Ritchlin C. Bone remodeling in psoriasis and psoriatic arthritis: an update. Current Opinion in Rheumatology 2016;28:66-75. [DOI: 10.1097/bor.0000000000000232] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
40 Turkcapar N, Toruner M, Soykan I, Aydintug OT, Cetinkaya H, Duzgun N, Ozden A, Duman M. The prevalence of extraintestinal manifestations and HLA association in patients with inflammatory bowel disease. Rheumatol Int. 2006;26:663-668. [PMID: 16136311 DOI: 10.1007/s00296-005-0044-9] [Cited by in Crossref: 98] [Cited by in F6Publishing: 81] [Article Influence: 5.8] [Reference Citation Analysis]
41 Bon L, Scharl S, Vavricka S, Rogler G, Fournier N, Pittet V, Scharl M, Greuter T, Schreiner P, Frei P, Misselwitz B, Biedermann L, Zeitz J; Swiss IBD Cohort Study Group. Association of IBD specific treatment and prevalence of pain in the Swiss IBD cohort study. PLoS One 2019;14:e0215738. [PMID: 31022217 DOI: 10.1371/journal.pone.0215738] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Langholz E. Current trends in inflammatory bowel disease: the natural history. Therap Adv Gastroenterol. 2010;3:77-86. [PMID: 21180592 DOI: 10.1177/1756283x10361304] [Cited by in Crossref: 52] [Cited by in F6Publishing: 21] [Article Influence: 4.7] [Reference Citation Analysis]
43 Wallis D, Inman RD. Recognition of Preclinical and Early Disease in Axial Spondyloarthritis. Rheumatic Disease Clinics of North America 2014;40:685-97. [DOI: 10.1016/j.rdc.2014.07.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
44 Braun J, Sieper J. Classification, Diagnosis, and Referral of Patients with Axial Spondyloarthritis. Rheumatic Disease Clinics of North America 2012;38:477-85. [DOI: 10.1016/j.rdc.2012.08.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
45 Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK, Hayee B, Lomer MCE, Parkes GC, Selinger C, Barrett KJ, Davies RJ, Bennett C, Gittens S, Dunlop MG, Faiz O, Fraser A, Garrick V, Johnston PD, Parkes M, Sanderson J, Terry H, Gaya DR, Iqbal TH, Taylor SA, Smith M, Brookes M, Hansen R, Hawthorne AB; IBD guidelines eDelphi consensus group. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:s1-s106. [PMID: 31562236 DOI: 10.1136/gutjnl-2019-318484] [Cited by in Crossref: 617] [Cited by in F6Publishing: 451] [Article Influence: 205.7] [Reference Citation Analysis]
46 Loftus EV Jr. Management of extraintestinal manifestations and other complications of inflammatory bowel disease. Curr Gastroenterol Rep. 2004;6:506-513. [PMID: 15527681 DOI: 10.1007/s11894-004-0073-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 34] [Article Influence: 2.6] [Reference Citation Analysis]
47 Olalekan SA, Cao Y, Finnegan A. Tissue specific CD4+ T cell priming determines the requirement for interleukin-23 in experimental arthritis. Arthritis Res Ther 2014;16:440. [PMID: 25253467 DOI: 10.1186/s13075-014-0440-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
48 Alnaqbi KA, Touma Z, Passalent L, Johnson SR, Tomlinson GA, Carty A, Inman RD. Development, sensibility, and reliability of the Toronto Axial Spondyloarthritis Questionnaire in inflammatory bowel disease. J Rheumatol 2013;40:1726-35. [PMID: 23996291 DOI: 10.3899/jrheum.130048] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
49 Siddique I, Alazmi W, Al-ali J, Longenecker JC, Al-fadli A, Hasan F, Memon A. Demography and clinical course of ulcerative colitis in Arabs – a study based on the Montreal classification. Scandinavian Journal of Gastroenterology 2014;49:1432-40. [DOI: 10.3109/00365521.2014.966318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Peeters H, Vander Cruyssen B, Laukens D, Coucke P, Marichal D, Van Den Berghe M, Cuvelier C, Remaut E, Mielants H, De Keyser F. Radiological sacroiliitis, a hallmark of spondylitis, is linked with CARD15 gene polymorphisms in patients with Crohn’s disease. Ann Rheum Dis. 2004;63:1131-1134. [PMID: 15308523 DOI: 10.1136/ard.2004.021774] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 3.2] [Reference Citation Analysis]
51 Brakenhoff LK, van der Heijde DM, Hommes DW, Huizinga TW, Fidder HH. The joint-gut axis in inflammatory bowel diseases. J Crohns Colitis. 2010;4:257-268. [PMID: 21122514 DOI: 10.1016/j.crohns.2009.11.005] [Cited by in Crossref: 74] [Cited by in F6Publishing: 56] [Article Influence: 5.7] [Reference Citation Analysis]
52 Barreiro-de Acosta M, Domínguez-Muñoz JE, Núñez-Pardo de Vera MC, Lozano-León A, Lorenzo A, Peña S. Relationship between clinical features of Crohn's disease and the risk of developing extraintestinal manifestations. Eur J Gastroenterol Hepatol 2007;19:73-8. [PMID: 17206080 DOI: 10.1097/01.meg.0000243883.47938.aa] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.4] [Reference Citation Analysis]
53 Büning C, Lochs H. Conventional therapy for Crohn’s disease. World J Gastroenterol 2006; 12(30): 4794-4806 [PMID: 16937460 DOI: 10.3748/wjg.v12.i30.4794] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
54 Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK. Crohn's disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci 2009;54:1099-107. [PMID: 18770037 DOI: 10.1007/s10620-008-0469-6] [Cited by in Crossref: 63] [Cited by in F6Publishing: 63] [Article Influence: 4.5] [Reference Citation Analysis]
55 Mizelle KV, Scott WW Jr, Gelber AC. Crohn ankylosis: a destructive elbow and wrist joint arthritis 2 decades following childhood abdominal pain. J Clin Rheumatol 2012;18:312-3. [PMID: 22955482 DOI: 10.1097/RHU.0b013e3182685648] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
56 Wolters FL, Russel MG, Stockbrügger RW. Systematic review: has disease outcome in Crohn’s disease changed during the last four decades? Aliment Pharmacol Ther. 2004;20:483-496. [PMID: 15339320 DOI: 10.1111/j.1365-2036.2004.02123.x] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 4.4] [Reference Citation Analysis]
57 Rajabally M, Watermeyer G, Levin D. A case of Crohn's disease complicated by Adult Onset Still's Disease. Journal of Crohn's and Colitis 2010;4:475-8. [DOI: 10.1016/j.crohns.2010.02.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
58 Parfenov AI, Kagramanova AV, Knyazev OV. [Systemic manifestations of inflammatory bowel diseases]. Ter Arkh 2020;92:4-11. [PMID: 32598711 DOI: 10.26442/00403660.2020.02.000535] [Reference Citation Analysis]
59 Atzeni F, Ardizzone S, Bertani L, Antivalle M, Batticciotto A, Sarzi-Puttini P. Combined therapeutic approach: Inflammatory bowel diseases and peripheral or axial arthritis. World J Gastroenterol 2009; 15(20): 2469-2471 [PMID: 19468996 DOI: 10.3748/wjg.15.2469] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]
60 Bjørkkjær T, Araujo P, Madland TM, Berstad A, Frøyland L. A randomized double blind comparison of short-term duodenally administrated whale and seal blubber oils in patients with inflammatory bowel disease and joint pain. Prostaglandins, Leukotrienes and Essential Fatty Acids 2009;81:425-32. [DOI: 10.1016/j.plefa.2009.07.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
61 Olpin JD, Sjoberg BP, Stilwill SE, Jensen LE, Rezvani M, Shaaban AM. Beyond the Bowel: Extraintestinal Manifestations of Inflammatory Bowel Disease. Radiographics. 2017;37:1135-1160. [PMID: 28548906 DOI: 10.1148/rg.2017160121] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
62 Thiebault H, Boyard-Lasselin P, Guignant C, Guillaume N, Wacrenier A, Sabbagh C, Rebibo L, Brazier F, Meynier J, Nguyen-Khac E, Dupas JL, Goëb V, Fumery M. Paradoxical articular manifestations in patients with inflammatory bowel diseases treated with infliximab. Eur J Gastroenterol Hepatol 2016;28:876-81. [PMID: 27101404 DOI: 10.1097/MEG.0000000000000643] [Cited by in Crossref: 19] [Cited by in F6Publishing: 4] [Article Influence: 3.8] [Reference Citation Analysis]
63 Rovisco J, Duarte C, Batticcioto A, Sarzi-Puttini P, Dragresshi A, Portela F, Gutierrez M. Hidden musculoskeletal involvement in inflammatory bowel disease: a multicenter ultrasound study. BMC Musculoskelet Disord 2016;17:84. [PMID: 26879247 DOI: 10.1186/s12891-016-0932-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
64 Sheth T, Pitchumoni CS, Das KM. Musculoskeletal manifestations in inflammatory bowel disease: a revisit in search of immunopathophysiological mechanisms. J Clin Gastroenterol. 2014;48:308-317. [PMID: 24492406 DOI: 10.1097/mcg.0000000000000067] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
65 Atay K, Eyvazov H, Bozcan S, Eşkazan T, Demir N, Hatemi İ, Erzin Y, Çelik AF. The effect of concomitant ankylosing spondylitis on long-term outcome of patients with inflammatory bowel disease. Turk J Gastroenterol 2019;30:599-604. [PMID: 31290746 DOI: 10.5152/tjg.2019.17291] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Wang H, Liu JS, Peng SH, Deng XY, Zhu DM, Javidiparsijani S, Wang GR, Li DQ, Li LX, Wang YC, Luo JM. Gut-lung crosstalk in pulmonary involvement with inflammatory bowel diseases. World J Gastroenterol 2013; 19(40): 6794-6804 [PMID: 24187454 DOI: 10.3748/wjg.v19.i40.6794] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 40] [Article Influence: 4.8] [Reference Citation Analysis]
67 Meier C, Plevy S. Therapy Insight: how the gut talks to the joints—inflammatory bowel disease and the spondyloarthropathies. Nat Rev Rheumatol 2007;3:667-74. [DOI: 10.1038/ncprheum0625] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
68 Conti F, Borrelli O, Anania C, Marocchi E, Romeo EF, Paganelli M, Valesini G, Cucchiara S. Chronic intestinal inflammation and seronegative spondyloarthropathy in children. Dig Liver Dis. 2005;37:761-767. [PMID: 16024303 DOI: 10.1016/j.dld.2005.04.028] [Cited by in Crossref: 12] [Cited by in F6Publishing: 17] [Article Influence: 0.8] [Reference Citation Analysis]
69 Fukunaga K, Sawada K, Fukuda Y, Matoba Y, Natsuaki M, Ohnishi K, Fukui S, Satomi M, Shimoyama T. Extracorporeal Monocyte Granulocytapheresis was Effective for a Patient of Erythema Nodosum Concomitant withUlcerative Colitis. Therapher Dial 2003;7:122-6. [DOI: 10.1046/j.1526-0968.2003.00002.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
70 Peluso R, DI Minno MN, Bruner V, Soscia E, Castiglione F, Manguso F, Iervolino S, Scarpa R. Discovertebral erosions in patients with enteropathic spondyloarthritis. J Rheumatol 2012;39:2332-40. [PMID: 23070989 DOI: 10.3899/jrheum.120415] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
71 Paredes JM, Barrachina MM, Román J, Moreno-Osset E. [Joint disease in inflammatory bowel disease]. Gastroenterol Hepatol 2005;28:240-9. [PMID: 15811268 DOI: 10.1157/13073095] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
72 Rondeau MP, Walton RM, Bissett S, Drobatz KJ, Washabau RJ. Suppurative, Nonseptic Polyarthropathy in Dogs. Journal of Veterinary Internal Medicine 2005;19:654-62. [DOI: 10.1111/j.1939-1676.2005.tb02743.x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
73 Garamszegi M. [Extraintestinal manifestations of inflammatory bowel diseases and their management]. Orv Hetil 2011;152:663-71. [PMID: 21464024 DOI: 10.1556/OH.2011.29075] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
74 Yamamoto-Furusho JK, Sánchez-Morales GE. Factors Associated with the Presence of Extraintestinal Manifestations in Patients with Ulcerative Colitis in a Latin American Country. Inflamm Intest Dis 2020;5:200-4. [PMID: 33313072 DOI: 10.1159/000510070] [Reference Citation Analysis]
75 Al-Jarallah K, Shehab D, Al-Azmi W, Al-Fadli A. Rheumatic complications of inflammatory bowel disease among Arabs: a hospital-based study in Kuwait. Int J Rheum Dis. 2013;16:134-138. [PMID: 23773636 DOI: 10.1111/j.1756-185x.2012.01811.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
76 Andres PG, Friedman LS. Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am. 1999;28:255-281, vii. [PMID: 10372268 DOI: 10.1016/s0889-8553(05)70056-x] [Cited by in Crossref: 197] [Cited by in F6Publishing: 58] [Article Influence: 8.6] [Reference Citation Analysis]
77 Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M, Burisch J, Gecse KB, Hart AL, Hindryckx P. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. J Crohns Colitis. 2017;11:649-670. [PMID: 28158501 DOI: 10.1093/ecco-jcc/jjx008] [Cited by in Crossref: 682] [Cited by in F6Publishing: 563] [Article Influence: 170.5] [Reference Citation Analysis]
78 Lin X, Lofland J, Zhang L, Sloan S, Chamaa L, Marano C, Plevy S. Opioid Use in Patients With Inflammatory Bowel Disease. Crohn's & Colitis 360 2020;2:otaa009. [DOI: 10.1093/crocol/otaa009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
79 Peña A. Contribution of genetics to a new vision in the understanding of inflammatory bowel disease. World J Gastroenterol 2006; 12(30): 4784-4787 [PMID: 16937458 DOI: 10.3748/wjg.v12.i30.4784] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
80 Arora G, Singh G, Vadhavkar S, Shah SB, Mannalithara A, Mithal A, Triadafilopoulos G. Incidence and Risk of Intestinal and Extra-intestinal Complications in Medicaid Patients with Inflammatory Bowel Disease: A 5-Year Population-Based Study. Dig Dis Sci 2010;55:1689-95. [DOI: 10.1007/s10620-010-1236-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
81 Burisch J, Jess T, Martinato M, Lakatos PL; ECCO -EpiCom. The burden of inflammatory bowel disease in Europe. J Crohns Colitis. 2013;7:322-337. [PMID: 23395397 DOI: 10.1016/j.crohns.2013.01.010] [Cited by in Crossref: 541] [Cited by in F6Publishing: 487] [Article Influence: 60.1] [Reference Citation Analysis]
82 Eksteen B, Liaskou E, Adams DH. Lymphocyte homing and its role in the pathogenesis of IBD. Inflamm Bowel Dis 2008;14:1298-312. [PMID: 18393377 DOI: 10.1002/ibd.20453] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
83 Alivernini S, Pugliese D, Tolusso B, Bui L, Petricca L, Guidi L, Mirone L, Rapaccini GL, Federico F, Ferraccioli G, Armuzzi A, Gremese E. Paradoxical arthritis occurring during anti-TNF in patients with inflammatory bowel disease: histological and immunological features of a complex synovitis. RMD Open 2018;4:e000667. [PMID: 29657833 DOI: 10.1136/rmdopen-2018-000667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
84 Subramanian S, Yajnik V, Sands BE, Cullen G, Korzenik JR. Characterization of patients with infliximab-induced lupus erythematosus and outcomes after retreatment with a second anti-TNF agent: . Inflammatory Bowel Diseases 2011;17:99-104. [DOI: 10.1002/ibd.21370] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 2.7] [Reference Citation Analysis]
85 Falloon K, Cohen B, Ananthakrishnan AN, Barnes EL, Bhattacharya A, Colombel JF, Cross RK, Driscoll MS, Fernandez AP, Ha C, Herfarth H, Horst S, Hou J, Husni ME, Kroshinsky D, Kuhn KA, Lowder CY, Martin G, Parikh D, Sayed CJ, Schocket L, Siaton BC, Vedak P, Weisman MH, Rieder F. A United States expert consensus to standardise definitions, follow-up, and treatment targets for extra-intestinal manifestations in inflammatory bowel disease. Aliment Pharmacol Ther 2022;55:1179-91. [PMID: 35277863 DOI: 10.1111/apt.16853] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
86 Peeters H, Vander Cruyssen B, Mielants H, de Vlam K, Vermeire S, Louis E, Rutgeerts P, Belaiche J, De Vos M. Clinical and genetic factors associated with sacroiliitis in Crohn's disease. J Gastroenterol Hepatol. 2008;23:132-137. [PMID: 17725592 DOI: 10.1111/j.1440-1746.2007.05108.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
87 Iacucci M, de Silva S, Ghosh S. Mesalazine in inflammatory bowel disease: a trendy topic once again? Can J Gastroenterol 2010;24:127-33. [PMID: 20151072 DOI: 10.1155/2010/586092] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 4.3] [Reference Citation Analysis]
88 Bandinelli F, Manetti M, Ibba-Manneschi L. Occult spondyloarthritis in inflammatory bowel disease. Clin Rheumatol 2016;35:281-9. [PMID: 26354428 DOI: 10.1007/s10067-015-3074-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
89 van Erp SJ, Brakenhoff LK, van Gaalen FA, van den Berg R, Fidder HH, Verspaget HW, Huizinga TW, Veenendaal RA, Wolterbeek R, van der Heijde D, van der Meulen-de Jong AE, Hommes DW. Classifying Back Pain and Peripheral Joint Complaints in Inflammatory Bowel Disease Patients: A Prospective Longitudinal Follow-up Study. ECCOJC 2016;10:166-75. [DOI: 10.1093/ecco-jcc/jjv195] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.9] [Reference Citation Analysis]
90 Gay G, Granel F, Regent D. Manifestations extra-intestinales des maladies inflammatoires chroniques de l’intestin (MICI). Acta Endosc 1999;29:263-81. [DOI: 10.1007/bf03019416] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
91 Felice C, Pugliese D, Papparella LG, Pizzolante F, Onori E, Gasbarrini A, Rapaccini GL, Guidi L, Armuzzi A. Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases. Expert Review of Clinical Immunology 2018;14:751-9. [DOI: 10.1080/1744666x.2018.1513329] [Cited by in Crossref: 7] [Article Influence: 1.8] [Reference Citation Analysis]
92 Annese V. A Review of Extraintestinal Manifestations and Complications of Inflammatory Bowel Disease. Saudi J Med Med Sci 2019;7:66-73. [PMID: 31080385 DOI: 10.4103/sjmms.sjmms_81_18] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
93 Vavricka SR, Schoepfer A, Scharl M, Lakatos PL, Navarini A, Rogler G. Extraintestinal Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis. 2015;21:1982-1992. [PMID: 26154136 DOI: 10.1097/mib.0000000000000392] [Cited by in Crossref: 256] [Cited by in F6Publishing: 103] [Article Influence: 42.7] [Reference Citation Analysis]
94 Bernstein CN, Blanchard JF, Rawsthorne P, Yu N. The Prevalence of Extraintestinal Diseases in Inflammatory Bowel Disease: A Population-Based Study: . American Journal of Gastroenterology 2001;96:1116-22. [DOI: 10.1111/j.1572-0241.2001.03756.x] [Cited by in Crossref: 441] [Cited by in F6Publishing: 388] [Article Influence: 21.0] [Reference Citation Analysis]
95 Danese S, Semeraro S, Papa A, Roberto I, Scaldaferri F, Fedeli G, Gasbarrini G, Gasbarrini A. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol. 2005;11:7227-7236. [PMID: 16437620 DOI: 10.3748/wjg.v11.i46.7227] [Cited by in CrossRef: 202] [Cited by in F6Publishing: 171] [Article Influence: 12.6] [Reference Citation Analysis]
96 Derfalvi B, Boros KK, Szabo D, Bozsaki G, Cseh A, Rudas G, Muller KE, Veres G. Joint involvement, disease activity and quality of life in pediatric Crohn’s disease – a cross-sectional study. Pediatr Rheumatol 2022;20. [DOI: 10.1186/s12969-022-00664-z] [Reference Citation Analysis]
97 Yap LM, Ahmad T, Jewell DP. The contribution of HLA genes to IBD susceptibility and phenotype. Best Pract Res Clin Gastroenterol. 2004;18:577-596. [PMID: 15157829 DOI: 10.1016/j.bpg.2004.01.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
98 Fragoulis GE, Liava C, Daoussis D, Akriviadis E, Garyfallos A, Dimitroulas T. Inflammatory bowel diseases and spondyloarthropathies: From pathogenesis to treatment. World J Gastroenterol 2019; 25(18): 2162-2176 [PMID: 31143068 DOI: 10.3748/wjg.v25.i18.2162] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 35] [Article Influence: 15.3] [Reference Citation Analysis]
99 Hiller A, Biedermann L, Fournier N, Butter M, Vavricka SR, Ciurea A, Rogler G, Scharl M; Swiss IBD Cohort Study Group. The appearance of joint manifestations in the Swiss inflammatory bowel disease cohort. PLoS One 2019;14:e0211554. [PMID: 31039159 DOI: 10.1371/journal.pone.0211554] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
100 Nikolaus S, Schreiber S. Diagnostics of inflammatory bowel disease. Gastroenterology. 2007;133:1670-1689. [PMID: 17983810 DOI: 10.1053/j.gastro.2007.09.001] [Cited by in Crossref: 256] [Cited by in F6Publishing: 223] [Article Influence: 17.1] [Reference Citation Analysis]
101 Rawal KK, Shukla VP, Chikani S, Thakkar M, Ruparelia M, Chudasama RK. Prevalence of extraintestinal manifestations in ulcerative colitis and associated risk factors. Indian J Gastroenterol 2021. [PMID: 34569013 DOI: 10.1007/s12664-021-01181-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
102 Alharbi OR, Azzam NA, Almalki AS, Almadi MA, Alswat KA, Sadaf N, Aljebreen AM. Clinical epidemiology of ulcerative colitis in Arabs based on the Montréal classification. World J Gastroenterol 2014; 20(46): 17525-17531 [PMID: 25516667 DOI: 10.3748/wjg.v20.i46.17525] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
103 Kazemi-Shirazi L, Gasche CH, Natter S, Gangl A, Smolen J, Spitzauer S, Valent P, Kraft D, Valenta R. IgA autoreactivity: a feature common to inflammatory bowel and connective tissue diseases. Clin Exp Immunol 2002;128:102-9. [PMID: 11982597 DOI: 10.1046/j.1365-2249.2002.01804.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
104 Yamamoto-Furusho JK, Rodríguez-Bores L, Granados J. HLA-DRB1 alleles are associated with the clinical course of disease and steroid dependence in Mexican patients with ulcerative colitis. Colorectal Dis 2010;12:1231-5. [PMID: 19674023 DOI: 10.1111/j.1463-1318.2009.02025.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
105 Florin TH, Graffner H, Nilsson L, Persson T. Treatment Of Joint Pain In Crohn's Patients With Budesonide Controlled Ileal Releases. Clin Exp Pharmacol Physiol 2000;27:295-8. [DOI: 10.1046/j.1440-1681.2000.03238.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
106 Evans J, Sapsford M, McDonald S, Poole K, Raine T, Jadon DR. Prevalence of axial spondyloarthritis in patients with inflammatory bowel disease using cross-sectional imaging: a systematic literature review. Ther Adv Musculoskelet Dis 2021;13:1759720X21996973. [PMID: 33786068 DOI: 10.1177/1759720X21996973] [Reference Citation Analysis]
107 Hablot J, Peyrin-Biroulet L, Kokten T, El Omar R, Netter P, Bastien C, Jouzeau JY, Sokol H, Moulin D. Experimental colitis delays and reduces the severity of collagen-induced arthritis in mice. PLoS One 2017;12:e0184624. [PMID: 28926599 DOI: 10.1371/journal.pone.0184624] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
108 De Keyser F, Baeten D, Van den Bosch F, De Vos M, Cuvelier C, Mielants H, Veys E. Gut inflammation and spondyloarthropathies. Curr Rheumatol Rep 2002;4:525-32. [PMID: 12427369 DOI: 10.1007/s11926-002-0061-6] [Cited by in Crossref: 54] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
109 Mendoza JL, Lana R, Martin MC, de la Concha EG, Urcelay E, Diaz-Rubio M, Abreu MT, Mitchell AA. FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease. Inflamm Bowel Dis 2009;15:1351-7. [PMID: 19235910 DOI: 10.1002/ibd.20895] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
110 Schwartzman M, Ermann J, Kuhn KA, Schwartzman S, Weisman MH. Spondyloarthritis in inflammatory bowel disease cohorts: systematic literature review and critical appraisal of study designs. RMD Open 2022;8:e001777. [PMID: 35046098 DOI: 10.1136/rmdopen-2021-001777] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
111 Martinis F, Tinazzi I, Bertolini E, Citriniti G, Variola A, Geccherle A, Marchetta A, McGonagle D, Macchioni P. Clinical and sonographic discrimination between fibromyalgia and spondyloarthopathy in inflammatory bowel disease with musculoskeletal pain. Rheumatology (Oxford) 2020;59:2857-63. [PMID: 32068873 DOI: 10.1093/rheumatology/keaa036] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
112 Bae JM, Choo JY, Kim KJ, Park KS. Association of inflammatory bowel disease with ankylosing spondylitis and rheumatoid arthritis: A nationwide population-based study. Mod Rheumatol 2017;27:435-40. [PMID: 27459267 DOI: 10.1080/14397595.2016.1211229] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.2] [Reference Citation Analysis]
113 Yamamoto-Furusho JK, Sarmiento-Aguilar A. Joint involvement in Mexican patients with ulcerative colitis: a hospital-based retrospective study. Clin Rheumatol 2018;37:677-82. [PMID: 28914369 DOI: 10.1007/s10067-017-3834-z] [Cited by in Crossref: 5] [Article Influence: 1.0] [Reference Citation Analysis]
114 Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005;129:827-836. [PMID: 16143122 DOI: 10.1053/j.gastro.2005.06.021] [Cited by in Crossref: 371] [Cited by in F6Publishing: 333] [Article Influence: 21.8] [Reference Citation Analysis]
115 Ardizzone S, Puttini PS, Cassinotti A, Porro GB. Extraintestinal manifestations of inflammatory bowel disease. Dig Liver Dis. 2008;40 Suppl 2:S253-S259. [PMID: 18598997 DOI: 10.1016/s1590-8658(08)60534-4] [Cited by in Crossref: 129] [Cited by in F6Publishing: 46] [Article Influence: 9.2] [Reference Citation Analysis]
116 Farhi D, Cosnes J, Zizi N, Chosidow O, Seksik P, Beaugerie L, Aractingi S, Khosrotehrani K. Significance of erythema nodosum and pyoderma gangrenosum in inflammatory bowel diseases: a cohort study of 2402 patients. Medicine (Baltimore). 2008;87:281-293. [PMID: 18794711 DOI: 10.1097/md.0b013e318187cc9c] [Cited by in Crossref: 105] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
117 Padovan M, Castellino G, Govoni M, Trotta F. The treatment of the rheumatological manifestations of the inflammatory bowel diseases. Rheumatol Int 2006;26:953-8. [DOI: 10.1007/s00296-006-0148-x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
118 Trikudanathan G, Venkatesh PG, Navaneethan U. Diagnosis and therapeutic management of extra-intestinal manifestations of inflammatory bowel disease. Drugs. 2012;72:2333-2349. [PMID: 23181971 DOI: 10.165/11638120-000000000-00000] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Siminovitch KA. Advances in the molecular dissection of inflammatory bowel disease. Semin Immunol. 2006;18:244-253. [PMID: 16679026 DOI: 10.1016/j.smim.2006.03.012] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
120 Kang SJ, Moon W, Park MI, Kim KJ, Kim JB, Park MJ, Park SJ, Chang HK. [Crohn's disease presenting with erythema nodosum as an early sign: a case report]. Korean J Gastroenterol 2011;58:103-6. [PMID: 21873826 DOI: 10.4166/kjg.2011.58.2.103] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
121 Hugot JP, Cho JH. Update on genetics of inflammatory bowel disease. Curr Opin Gastroenterol. 2002;18:410-415. [PMID: 17033314 DOI: 10.1097/00001574-200207000-00003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
122 Puri AS. Epidemiology of Ulcerative Colitis in South Asia. Intest Res 2013;11:250. [DOI: 10.5217/ir.2013.11.4.250] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
123 Bjørkkjaer T, Brun JG, Valen M, Arslan G, Lind R, Brunborg LA, Berstad A, Frøyland L. Short-term duodenal seal oil administration normalised n-6 to n-3 fatty acid ratio in rectal mucosa and ameliorated bodily pain in patients with inflammatory bowel disease. Lipids Health Dis 2006;5:6. [PMID: 16549021 DOI: 10.1186/1476-511X-5-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
124 Rodríguez-Reyna TS, Martínez-Reyes C, Yamamoto-Furusho JK. Rheumatic manifestations of inflammatory bowel disease. World J Gastroenterol 2009; 15(44): 5517-5524 [PMID: 19938189 DOI: 10.3748/wjg.15.5517] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 47] [Article Influence: 4.7] [Reference Citation Analysis]
125 Kumar A, Lukin D, Battat R, Schwartzman M, Mandl LA, Scherl E, Longman RS. Defining the phenotype, pathogenesis and treatment of Crohn's disease associated spondyloarthritis. J Gastroenterol 2020;55:667-78. [PMID: 32367294 DOI: 10.1007/s00535-020-01692-w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
126 Kvasnovsky CL, Aujla U, Bjarnason I. Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:255-263. [PMID: 25314574 DOI: 10.3109/00365521.2014.966753] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
127 Gerson LB, Triadafilopoulos G. Palliative Care in Inflammatory Bowel Disease: An Evidence-Based Approach: . Inflammatory Bowel Diseases 2000;6:228-43. [DOI: 10.1097/00054725-200008000-00009] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
128 Sood A, Ahuja V, Midha V, Sinha SK, Pai CG, Kedia S, Mehta V, Bopanna S, Abraham P, Banerjee R, Bhatia S, Chakravartty K, Dadhich S, Desai D, Dwivedi M, Goswami B, Kaur K, Khosla R, Kumar A, Mahajan R, Misra SP, Peddi K, Singh SP, Singh A. Colitis and Crohn's Foundation (India) consensus statements on use of 5-aminosalicylic acid in inflammatory bowel disease. Intest Res 2020;18:355-78. [PMID: 32646198 DOI: 10.5217/ir.2019.09176] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
129 Peluso R, Di Minno MN, Iervolino S, Manguso F, Tramontano G, Ambrosino P, Esposito C, Scalera A, Castiglione F, Scarpa R. Enteropathic spondyloarthritis: from diagnosis to treatment. Clin Dev Immunol. 2013;2013:631408. [PMID: 23690825 DOI: 10.1155/2013/631408] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
130 Sands BE, Siegel CA. Crohn's Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Elsevier; 2010. pp. 1941-1973.e9. [DOI: 10.1016/b978-1-4160-6189-2.00111-6] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
131 Salvarani C, Fornaciari G, Beltrami M, Macchioni PL. Musculoskeletal manifestations in inflammatory bowel disease. Eur J Intern Med. 2000;11:210-214. [PMID: 10967509 DOI: 10.1016/s0953-6205(00)00093-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
132 García-porrúa C, González-gay MA, González-louzao C, Castro J, Rivas MJ, Santos E. Uncommon arthritis as presenting manifestation of silent Crohn’s disease. Joint Bone Spine 2000;67:553-4. [DOI: 10.1016/s1297-319x(00)00220-7] [Reference Citation Analysis]
133 Bernstein CN. Neoplastic and other complications of inflammatory bowel disease. Curr Gastroenterol Rep 2000;2:451-9. [DOI: 10.1007/s11894-000-0007-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
134 Kiely PDW, Lloyd ME. Ankle arthritis - an important signpost in rheumatologic practice. Rheumatology (Oxford) 2021;60:23-33. [PMID: 33097958 DOI: 10.1093/rheumatology/keaa531] [Reference Citation Analysis]
135 Grant AJ, Lalor PF, Salmi M, Jalkanen S, Adams DH. Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease. The Lancet 2002;359:150-7. [DOI: 10.1016/s0140-6736(02)07374-9] [Cited by in Crossref: 169] [Cited by in F6Publishing: 50] [Article Influence: 8.5] [Reference Citation Analysis]
136 Lourenco SV, Boggio P, Bernardelli IM, Nico MMS. Oral ulcers on the vestibular sulci. Clin Exp Dermatol 2006;31:735-6. [DOI: 10.1111/j.1365-2230.2006.02096.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
137 Kuenzig ME, Sadatsafavi M, Aviña-Zubieta JA, Burne RM, Abrahamowicz M, Beauchamp ME, Kaplan GG, Benchimol EI. Asthma is not associated with the need for surgery in Crohn's disease when controlling for smoking status: a population-based cohort study. Clin Epidemiol 2018;10:831-40. [PMID: 30038523 DOI: 10.2147/CLEP.S156772] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
138 Cross RK, Jung C, Wasan S, Joshi G, Sawyer R, Roghmann MC. Racial differences in disease phenotypes in patients with Crohn's disease. Inflamm Bowel Dis. 2006;12:192-198. [PMID: 16534420 DOI: 10.1097/01.mib.0000217767.98389.20] [Cited by in Crossref: 40] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
139 Demir FT, Kocatürk E, Yorulmaz E, Adali G, Kavala M. Mucocutaneous Manifestations of Inflammatory Bowel Disease in Turkey. J Cutan Med Surg 2014;18:397-404. [DOI: 10.2310/7750.2014.13209] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
140 Farhi D, Cosnes J, Aractingi S, Khosrotehrani K. [Cutaneous manifestations associated with chronic inflammatory bowel disease]. Ann Dermatol Venereol 2009;136:828-33; 826-7, 834-5. [PMID: 19917440 DOI: 10.1016/j.annder.2008.10.045] [Reference Citation Analysis]
141 Rothfuss KS, Stange EF, Herrlinger KR. Extraintestinal manifestations and complications in inflammatory bowel diseases. World J Gastroenterol 2006; 12(30): 4819-4831 [PMID: 16937463 DOI: 10.3748/wjg.v12.i30.4819] [Cited by in CrossRef: 175] [Cited by in F6Publishing: 147] [Article Influence: 10.9] [Reference Citation Analysis]
142 Smale S, Natt RS, Orchard TR, Russell AS, Bjarnason I. Inflammatory bowel disease and spondylarthropathy. Arthritis Rheum 2001;44:2728-36. [PMID: 11762932 DOI: 10.1002/1529-0131(200112)44:12<2728::aid-art459>3.0.co;2-8] [Cited by in Crossref: 74] [Cited by in F6Publishing: 25] [Article Influence: 3.7] [Reference Citation Analysis]
143 Zanger K, Nimkin K, Israel EJ, Shih AR. Case 3-2022: A 14-Year-Old Boy with Fever, Joint Pain, and Abdominal Cramping. N Engl J Med 2022;386:375-83. [PMID: 35081284 DOI: 10.1056/NEJMcpc2115850] [Reference Citation Analysis]
144 Papamichael K, Tsirogianni A, Papasteriades C, Mantzaris GJ. Low prevalence of antibodies to cyclic citrullinated peptide in patients with inflammatory bowel disease regardless of the presence of arthritis. Eur J Gastroenterol Hepatol 2010;22:705-9. [PMID: 19525851 DOI: 10.1097/MEG.0b013e32832e2bc4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
145 Wollheim FA. Enteropathic arthritis: how do the joints talk with the gut? Curr Opin Rheumatol 2001;13:305-9. [PMID: 11555733 DOI: 10.1097/00002281-200107000-00011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
146 Salvarani C, Fries W. Clinical features and epidemiology of spondyloarthritides associated with inflammatory bowel disease. World J Gastroenterol. 2009;15:2449-2455. [PMID: 19468993 DOI: 10.3748/wjg.15.2449.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
147 Variola A, Zanolin ME, Cipriano G, Macchioni P, Martinis F, Pasetti A, Grassi M, Geccherle A, Marchetta A, Mcgonagle D, Tinazzi I. The IBIS-Q [IBd Identification of Spondyloarthritis Questionnaire]: A Novel Tool to Detect Both Axial and Peripheral Arthritis in Inflammatory Bowel Disease Patients. Journal of Crohn's and Colitis 2020;14:1680-6. [DOI: 10.1093/ecco-jcc/jjaa096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Moeller JL. Inflammatory bowel disease arthropathy. Curr Sports Med Rep 2005;4:105-7. [PMID: 15763048 DOI: 10.1097/01.csmr.0000306082.20688.8e] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
149 Resende GG, Lanna CC, Bortoluzzo AB, Gonçalves CR, Sampaio-barros PD, Silva JABD, Ximenes AC, Bértolo MB, Ribeiro SL, Keiserman M, Menin R, Skare TL, Carneiro S, Azevedo VF, Vieira WP, Albuquerque EN, Bianchi WA, Bonfiglioli R, Campanholo C, Carvalho HM, Costa IP, Duarte AP, Kohem CL, Leite N, Lima SA, Meirelles ES, Pereira IA, Pinheiro MM, Polito E, Rocha FAC, Santiago MB, Sauma MDFL, Valim V. Artrite enteropática no Brasil: dados do registro brasileiro de espondiloartrites. Revista Brasileira de Reumatologia 2013;53:452-9. [DOI: 10.1016/j.rbr.2013.04.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
150 Šošo D, Aljinović J, Lovrić Kojundžić S, Marinović I, Čečuk Jeličić E, Marasović Krstulović D. Ultrasound-Verified Peripheral Arthritis in Patients with HLA-B*35 Positive Spondyloarthritis. Life (Basel) 2021;11:524. [PMID: 34199710 DOI: 10.3390/life11060524] [Reference Citation Analysis]
151 Castro M, Papadatou B, Baldassare M, Balli F, Barabino A, Barbera C, Barca S, Barera G, Bascietto F, Berni Canani R, Calacoci M, Campanozzi A, Castellucci G, Catassi C, Colombo M, Covoni MR, Cucchiara S, D'Altilia MR, De Angelis GL, De Virgilis S, Di Ciommo V, Fontana M, Guariso G, Knafelz D, Lambertini A, Licciardi S, Lionetti P, Liotta L, Lombardi G, Maestri L, Martelossi S, Mastella G, Oderda G, Perini R, Pesce F, Ravelli A, Roggero P, Romano C, Rotolo N, Rutigliano V, Scotta S, Sferlazzas C, Staiano A, Ventura A, Zaniboni MG. Inflammatory bowel disease in children and adolescents in Italy: data from the pediatric national IBD register (1996-2003). Inflamm Bowel Dis. 2008;14:1246-1252. [PMID: 18521916 DOI: 10.1002/ibd.20470] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 6.0] [Reference Citation Analysis]
152 Cai T, Lin TC, Bond A, Huang J, Kane-Wanger G, Cagan A, Murphy SN, Ananthakrishnan AN, Liao KP. The Association Between Arthralgia and Vedolizumab Using Natural Language Processing. Inflamm Bowel Dis. 2018;24:2242-2246. [PMID: 29846617 DOI: 10.1093/ibd/izy127] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
153 Núñez C, Alecsandru DM, Mendoza JL, Urcelay E, Díaz-Rubio M, de la Concha EG, Martinez A. Genetic markers linked to rheumatoid arthritis are also strongly associated with articular manifestations in ulcerative colitis patients. Hum Immunol 2006;67:324-30. [PMID: 16720213 DOI: 10.1016/j.humimm.2006.02.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
154 Roth R, Vavricka S, Scharl M, Schreiner P, Safroneeva E, Greuter T, Zeitz J, Misselwitz B, Schoepfer A, Barry MP, Rogler G, Biedermann L; Swiss IBD cohort study. The impact of colectomy on the course of extraintestinal manifestations in Swiss inflammatory bowel disease cohort study patients. United European Gastroenterol J 2021. [PMID: 34431613 DOI: 10.1002/ueg2.12125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Evans DM, Reveille JD, Brown MA, Chandran V, Gladman DD, Martin TM, Mcgovern D, Wordsworth P, Inman RD. The Genetic Basis of Spondyloarthritis: SPARTAN/IGAS 2009. J Rheumatol 2010;37:2626-31. [DOI: 10.3899/jrheum.100892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
156 Zakaria AA, Rifat SF. Inflammatory Bowel Disease: Concerns for the Athlete. Current Sports Medicine Reports 2008;7:104-7. [DOI: 10.1097/01.csmr.0000313398.94816.47] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
157 Zippi M, Corrado C, Pica R, Avallone EV, Cassieri C, De Nitto D, Paoluzi P, Vernia P. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. World J Gastroenterol 2014; 20(46): 17463-17467 [PMID: 25516659 DOI: 10.3748/wjg.v20.i46.17463] [Cited by in CrossRef: 61] [Cited by in F6Publishing: 51] [Article Influence: 7.6] [Reference Citation Analysis]
158 Dotson JL, Hyams JS, Markowitz J, Leleiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-hemker M, Langton CR, Crandall W. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease and Their Relation to Disease Type and Severity. Journal of Pediatric Gastroenterology & Nutrition 2010;51:140-5. [DOI: 10.1097/mpg.0b013e3181ca4db4] [Cited by in Crossref: 91] [Cited by in F6Publishing: 19] [Article Influence: 7.6] [Reference Citation Analysis]
159 Bandyopadhyay D, Bandyopadhyay S, Ghosh P, De A, Bhattacharya A, Dhali GK, Das K. Extraintestinal manifestations in inflammatory bowel disease: Prevalence and predictors in Indian patients. Indian J Gastroenterol. 2015;34:387-394. [PMID: 26614005 DOI: 10.1007/s12664-015-0598-8] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.4] [Reference Citation Analysis]
160 Lanna CC, Ferrari Mde L, Rocha SL, Nascimento E, de Carvalho MA, da Cunha AS. A cross-sectional study of 130 Brazilian patients with Crohn's disease and ulcerative colitis: analysis of articular and ophthalmologic manifestations. Clin Rheumatol 2008;27:503-9. [PMID: 18097711 DOI: 10.1007/s10067-007-0797-5] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 3.7] [Reference Citation Analysis]
161 Brunborg LA, Madland TM, Lind RA, Arslan G, Berstad A, Frøyland L. Effects of short-term oral administration of dietary marine oils in patients with inflammatory bowel disease and joint pain: A pilot study comparing seal oil and cod liver oil. Clinical Nutrition 2008;27:614-22. [DOI: 10.1016/j.clnu.2008.01.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 1.4] [Reference Citation Analysis]
162 Jang HJ, Kang B, Choe BH. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Transl Pediatr 2019;8:4-15. [PMID: 30881893 DOI: 10.21037/tp.2019.01.06] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
163 Scher JU, Ubeda C, Artacho A, Attur M, Isaac S, Reddy SM, Marmon S, Neimann A, Brusca S, Patel T, Manasson J, Pamer EG, Littman DR, Abramson SB. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol. 2015;67:128-139. [PMID: 25319745 DOI: 10.1002/art.38892] [Cited by in Crossref: 352] [Cited by in F6Publishing: 336] [Article Influence: 50.3] [Reference Citation Analysis]
164 Bjarnason I, Helgason KO, Geirsson AJ, Sigthorsson G, Reynisdottir I, Gudbjartsson D, Einarsdottir AS, Sherwood R, Kristjansson K, Kjartansson O, Thjodleifsson B. Subclinical intestinal inflammation and sacroiliac changes in relatives of patients with ankylosing spondylitis. Gastroenterology 2003;125:1598-605. [PMID: 14724811 DOI: 10.1053/j.gastro.2003.08.035] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 2.2] [Reference Citation Analysis]
165 Ke K, Arra M, Abu-Amer Y. Mechanisms Underlying Bone Loss Associated with Gut Inflammation. Int J Mol Sci 2019;20:E6323. [PMID: 31847438 DOI: 10.3390/ijms20246323] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
166 Walker D, Orchard T. Do extraintestinal manifestations predict disease course, severity, and/or activity in IBD?: . Inflammatory Bowel Diseases 2008;14:S200-1. [DOI: 10.1002/ibd.20637] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
167 Juliao-Baños F, Arrubla M, Osorio L, Camargo J, Londoño J, Cáceres C, Carvajal J, Mosquera-Klinger G, Donado J. Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia. Gastroenterol Hepatol 2021;44:398-404. [PMID: 33172691 DOI: 10.1016/j.gastrohep.2020.07.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
168 Allez M, Modigliani R. Clinical features of inflammatory bowel disease. Curr Opin Gastroenterol 2000;16:329-36. [PMID: 17031097 DOI: 10.1097/00001574-200007000-00007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
169 Sauer C, Gutgesell M. Ballet Dancer with Hip and Groin Pain: Crohn Disease and Psoas Abscess. Clin Pediatr (Phila) 2005;44:731-3. [DOI: 10.1177/000992280504400814] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
170 Perez-alamino R, Maldonado-ficco H, Maldonado-cocco JA. Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology. Clin Rheumatol 2016;35:291-6. [DOI: 10.1007/s10067-015-3116-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
171 Märker-Hermann E. [Early spondyloarthritis]. Internist (Berl) 2008;49:271-7. [PMID: 18265956 DOI: 10.1007/s00108-007-2010-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
172 Klingberg E, Strid H, Ståhl A, Deminger A, Carlsten H, Öhman L, Forsblad-d'Elia H. A longitudinal study of fecal calprotectin and the development of inflammatory bowel disease in ankylosing spondylitis. Arthritis Res Ther 2017;19:21. [PMID: 28148281 DOI: 10.1186/s13075-017-1223-2] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 7.6] [Reference Citation Analysis]
173 Schrijver IA, De Man YA, Melief MJ, Van Laar JM, Markusse HM, Klasen IS, Hazenberg MP, Laman JD. Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients. Clin Exp Immunol 2001;123:140-6. [PMID: 11168011 DOI: 10.1046/j.1365-2249.2001.01419.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
174 Mohamed Said MS, Shaharir S, Rajalingham S, Abdullah SA, Bin Hassanudin A, Soon NC, Shahid MS. Etanercept in the treatment of recalcitrant enteropathic arthritis: a case report. J Med Case Rep 2012;6:10. [PMID: 22236863 DOI: 10.1186/1752-1947-6-10] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
175 Braun J, Baraliakos X, Kiltz U, Heldmann F, Sieper J. Classification and Diagnosis of Axial Spondyloarthritis — What Is the Clinically Relevant Difference? J Rheumatol 2015;42:31-8. [DOI: 10.3899/jrheum.130959] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 3.4] [Reference Citation Analysis]
176 Arvikar SL, Fisher MC. Inflammatory bowel disease associated arthropathy. Curr Rev Musculoskelet Med. 2011;4:123-131. [PMID: 21710141 DOI: 10.1007/s12178-011-9085-8] [Cited by in Crossref: 64] [Cited by in F6Publishing: 50] [Article Influence: 5.8] [Reference Citation Analysis]
177 Baeten D, De Keyser F, Mielants H, Veys EM. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2002;16:537-549. [PMID: 12406426 DOI: 10.1053/berh.2002.0249] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 1.6] [Reference Citation Analysis]
178 Orchard TR, Chua CN, Ahmad T, Cheng H, Welsh KI, Jewell DP. Uveitis and erythema nodosum in inflammatory bowel disease: clinical features and the role of HLA genes. Gastroenterology. 2002;123:714-718. [PMID: 12198697 DOI: 10.1053/gast.2002.35396] [Cited by in Crossref: 153] [Cited by in F6Publishing: 125] [Article Influence: 7.7] [Reference Citation Analysis]
179 Chimenti MS, Perricone C, D'Antonio A, Ferraioli M, Conigliaro P, Triggianese P, Ciccacci C, Borgiani P, Perricone R. Genetics, Epigenetics, and Gender Impact in Axial-Spondyloarthritis Susceptibility: An Update on Genetic Polymorphisms and Their Sex Related Associations. Front Genet 2021;12:671976. [PMID: 34447407 DOI: 10.3389/fgene.2021.671976] [Reference Citation Analysis]
180 Atzeni F, Defendenti C, Ditto MC, Batticciotto A, Ventura D, Antivalle M, Ardizzone S, Sarzi-Puttini P. Rheumatic manifestations in inflammatory bowel disease. Autoimmun Rev. 2014;13:20-23. [PMID: 23774109 DOI: 10.1016/j.autrev.2013.06.006] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 4.4] [Reference Citation Analysis]
181 Olivieri I, Cantini F, Castiglione F, Felice C, Gionchetti P, Orlando A, Salvarani C, Scarpa R, Vecchi M, Armuzzi A. Italian Expert Panel on the management of patients with coexisting spondyloarthritis and inflammatory bowel disease. Autoimmun Rev. 2014;13:822-830. [PMID: 24726868 DOI: 10.1016/j.autrev.2014.04.003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 6.9] [Reference Citation Analysis]
182 Abraham BP. Symptom management in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 2015;9:953-67. [DOI: 10.1586/17474124.2015.1038241] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
183 Sarbu MI, Sarbu N. Musculoskeletal Clinical and Imaging Manifestations in Inflammatory Bowel Diseases. Open Med (Wars) 2019;14:75-84. [PMID: 30847394 DOI: 10.1515/med-2019-0011] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
184 Orzechowski NM, Mason TG. Seronegative Inflammatory Arthritis. Morrey's The Elbow and Its Disorders. Elsevier; 2009. pp. 1039-42. [DOI: 10.1016/b978-1-4160-2902-1.50080-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
185 Malaty HM, Lo GH, Hou JK. Characterization and prevalence of spondyloarthritis and peripheral arthritis among patients with inflammatory bowel disease. Clin Exp Gastroenterol 2017;10:259-63. [PMID: 29026327 DOI: 10.2147/CEG.S136383] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 2.4] [Reference Citation Analysis]
186 Chan SS, Hart AR. Aspirin use and development of inflammatory bowel disease: confounding or causation? authors' reply. Aliment Pharmacol Ther 2011;34:1351. [PMID: 22085379 DOI: 10.1111/j.1365-2036.2011.04885.x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
187 Generini S, Giacomelli R, Fedi R, Fulminis A, Pignone A, Frieri G, Del Rosso A, Viscido A, Galletti B, Fazzi M. Infliximab in spondyloarthropathy associated with Crohn’s disease: an open study on the efficacy of inducing and maintaining remission of musculoskeletal and gut manifestations. Ann Rheum Dis. 2004;63:1664-1669. [PMID: 15297279 DOI: 10.1136/ard.2003.012450] [Cited by in Crossref: 90] [Cited by in F6Publishing: 68] [Article Influence: 5.0] [Reference Citation Analysis]
188 Jansen FM, Vavricka SR, den Broeder AA, de Jong EM, Hoentjen F, van Dop WA. Clinical management of the most common extra-intestinal manifestations in patients with inflammatory bowel disease focused on the joints, skin and eyes. United European Gastroenterol J 2020;8:1031-44. [PMID: 32921269 DOI: 10.1177/2050640620958902] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
189 Finucci A, Ditto MC, Parisi S, Borrelli R, Priora M, Realmuto C, Fusaro E. Rheumatic manifestations in inflammatory bowel disease. Minerva Gastroenterol (Torino) 2021;67:79-90. [PMID: 32623869 DOI: 10.23736/S2724-5985.20.02726-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
190 Zeitz J, Ak M, Müller-Mottet S, Scharl S, Biedermann L, Fournier N, Frei P, Pittet V, Scharl M, Fried M. Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account. PLoS One. 2016;11:e0156666. [PMID: 27332879 DOI: 10.1371/journal.pone.0156666] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 8.5] [Reference Citation Analysis]
191 Yi F, Chen M, Huang M, Li J, Zhao J, Li L, Xia B. The trend in newly diagnosed Crohn’s disease and extraintestinal manifestations of Crohn’s disease in central China: a retrospective study of a single center. Eur J Gastroenterol Hepatol. 2012;24:1424-1429. [PMID: 22895389 DOI: 10.1097/meg.0b013e3283583e5c] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
192 Greuter T, Vavricka SR. Extraintestinal manifestations in inflammatory bowel disease – epidemiology, genetics, and pathogenesis. Expert Review of Gastroenterology & Hepatology 2019;13:307-17. [DOI: 10.1080/17474124.2019.1574569] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
193 Bataduwaarachchi VR, Fenandopulle N, Liyanage U, Jayasundara C. The concurrent association of inflammatory polymyositis and Crohn's ileo-colitis in a Sri Lankan man: a case report of a rare association and literature review. BMC Gastroenterol 2014;14:35. [PMID: 24552185 DOI: 10.1186/1471-230X-14-35] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
194 Chan J, Sari I, Salonen D, Silverberg MS, Haroon N, Inman RD. Prevalence of Sacroiliitis in Inflammatory Bowel Disease Using a Standardized Computed Tomography Scoring System. Arthritis Care Res 2018;70:807-10. [DOI: 10.1002/acr.23323] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
195 Van Assche G, Dignass A, Reinisch W, van der Woude CJ, Sturm A, De Vos M, Guslandi M, Oldenburg B, Dotan I, Marteau P. The second European evidence-based Consensus on the diagnosis and management of Crohn’s disease: Special situations. J Crohns Colitis. 2010;4:63-101. [PMID: 21122490 DOI: 10.1016/j.crohns.2009.09.009] [Cited by in Crossref: 540] [Cited by in F6Publishing: 466] [Article Influence: 41.5] [Reference Citation Analysis]
196 Hansen JJ. Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases. Curr Allergy Asthma Rep. 2015;15:61. [PMID: 26306907 DOI: 10.1007/s11882-015-0562-9] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 4.3] [Reference Citation Analysis]
197 Rizzo A, Ferrante A, Guggino G, Ciccia F. Gut inflammation in spondyloarthritis. Best Practice & Research Clinical Rheumatology 2017;31:863-76. [DOI: 10.1016/j.berh.2018.08.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
198 Adams DH, Eksteen B. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease. Nat Rev Immunol. 2006;6:244-251. [PMID: 16498453 DOI: 10.1038/nri1784] [Cited by in Crossref: 196] [Cited by in F6Publishing: 171] [Article Influence: 12.3] [Reference Citation Analysis]
199 Yang BR, Choi NK, Kim MS, Chun J, Joo SH, Kim H, Lee J. Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients. PLoS One. 2018;13:e0200363. [PMID: 29990326 DOI: 10.1371/journal.pone.0200363] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
200 D’incà R, Podswiadek M, Ferronato A, Punzi L, Salvagnini M, Sturniolo G. Articular manifestations in inflammatory bowel disease patients: A prospective study. Digestive and Liver Disease 2009;41:565-9. [DOI: 10.1016/j.dld.2009.01.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
201 Conigliaro P, Chimenti MS, Ascolani M, Triggianese P, Novelli L, Onali S, Lolli E, Calabrese E, Petruzziello C, Pallone F. Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients. Autoimmun Rev. 2016;15:184-190. [PMID: 26554932 DOI: 10.1016/j.autrev.2015.11.002] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
202 Ditisheim S, Fournier N, Juillerat P, Pittet V, Michetti P, Gabay C, Finckh A. Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study. Inflammatory Bowel Diseases 2015;21:2598-604. [DOI: 10.1097/mib.0000000000000548] [Cited by in Crossref: 23] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
203 Saibeni S, Spina L, Virgilio T, Folcioni A, Borsi G, de Franchis R, Cugno M, Vecchi M. Angiotensin-converting enzyme insertion/deletion gene polymorphism in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 2007;19:976-81. [PMID: 18049167 DOI: 10.1097/MEG.0b013e3282efa3fc] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
204 Rudwaleit M, Baeten D. Ankylosing spondylitis and bowel disease. Best Pract Res Clin Rheumatol. 2006;20:451-471. [PMID: 16777576 DOI: 10.1016/j.berh.2006.03.010] [Cited by in Crossref: 117] [Cited by in F6Publishing: 99] [Article Influence: 7.3] [Reference Citation Analysis]
205 Wordsworth BP, Cohen CJ, Davidson C, Vecellio M. Perspectives on the Genetic Associations of Ankylosing Spondylitis. Front Immunol 2021;12:603726. [PMID: 33746951 DOI: 10.3389/fimmu.2021.603726] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Cardile S, Romano C. Current issues in pediatric inflammatory bowel disease-associated arthropathies. World J Gastroenterol 2014; 20(1): 45-52 [PMID: 24415857 DOI: 10.3748/wjg.v20.i1.45] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
207 Chen Y, Chen L, Xing C, Deng G, Zeng F, Xie T, Gu L, Yang H. The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol 2020;20:192. [PMID: 32552882 DOI: 10.1186/s12876-020-01339-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
208 González S, Rodrigo L, Martínez-Borra J, López-Vázquez A, Fuentes D, Niño P, Cadahía V, Saro C, Dieguez MA, López-Larrea C. TNF-alpha -308A promoter polymorphism is associated with enhanced TNF-alpha production and inflammatory activity in Crohn's patients with fistulizing disease. Am J Gastroenterol 2003;98:1101-6. [PMID: 12809834 DOI: 10.1111/j.1572-0241.2003.07416.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 37] [Article Influence: 0.9] [Reference Citation Analysis]
209 Zochling J, Smith EU. Seronegative spondyloarthritis. Best Pract Res Clin Rheumatol 2010;24:747-56. [PMID: 21665123 DOI: 10.1016/j.berh.2011.02.002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
210 Schrijver IA, Melief MJ, Tak PP, Hazenberg MP, Laman JD. Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines. Arthritis Rheum 2000;43:2160-8. [PMID: 11037875 DOI: 10.1002/1529-0131(200010)43:10<2160::AID-ANR3>3.0.CO;2-T] [Cited by in Crossref: 66] [Cited by in F6Publishing: 25] [Article Influence: 3.0] [Reference Citation Analysis]
211 Orchard TR, Jewell DP. The importance of ileocaecal integrity in the arthritic complications of Crohn's disease. Inflamm Bowel Dis 1999;5:92-7. [PMID: 10338377 DOI: 10.1097/00054725-199905000-00004] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
212 Fauny M, Cohen N, Morizot C, Leclerc-Jacob S, Wendling D, Lux G, Laurent V, Blum A, Netter P, Baumann C, Chary-Valckenaere I, Peyrin-Biroulet L, Loeuille D. Low Back Pain and Sacroiliitis on Cross-Sectional Abdominal Imaging for Axial Spondyloarthritis Diagnosis in Inflammatory Bowel Diseases. Inflamm Intest Dis 2020;5:124-31. [PMID: 32999885 DOI: 10.1159/000507930] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
213 Kethu SR. Extraintestinal Manifestations of Inflammatory Bowel Diseases: . Journal of Clinical Gastroenterology 2006;40:467-75. [DOI: 10.1097/00004836-200607000-00003] [Cited by in Crossref: 39] [Cited by in F6Publishing: 28] [Article Influence: 2.4] [Reference Citation Analysis]
214 Holden W, Orchard T, Wordsworth P. Enteropathic arthritis. Rheumatic Disease Clinics of North America 2003;29:513-30. [DOI: 10.1016/s0889-857x(03)00043-7] [Cited by in Crossref: 61] [Cited by in F6Publishing: 12] [Article Influence: 3.2] [Reference Citation Analysis]
215 Nemet AY, Vinker S, Bahar I, Kaiserman I. The association of keratoconus with immune disorders. Cornea 2010;29:1261-4. [PMID: 20802320 DOI: 10.1097/ICO.0b013e3181cb410b] [Cited by in Crossref: 86] [Cited by in F6Publishing: 23] [Article Influence: 7.8] [Reference Citation Analysis]
216 Torres JADP, Santana RMD, Torres FADP, Moura AR, Torres Neto JDR. Doenças inflamatórias intestinais no Hospital Universitário da Universidade Federal de Sergipe: manifestações extraintestinais. Rev bras colo-proctol 2011;31:115-9. [DOI: 10.1590/s0101-98802011000200001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
217 Brown SR, Coviello LC. Extraintestinal Manifestations Associated with Inflammatory Bowel Disease. Surg Clin North Am. 2015;95:1245-159, vii. [PMID: 26596925 DOI: 10.1016/j.suc.2015.08.002] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
218 Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators:. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol 2022;60:332-418. [PMID: 35263784 DOI: 10.1055/a-1713-3941] [Reference Citation Analysis]
219 El-Hodhod MA, Aly RH, Youssef SR, Mohamed SI. Enhanced blood lymphocytes apoptosis in children with inflammatory bowel disease. ISRN Gastroenterol 2013;2013:415417. [PMID: 24073337 DOI: 10.1155/2013/415417] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
220 Nakamura M, Ikeuchi H, Nakano H, Uchino M, Noda M, Yanagi H, Yamamura T. Postoperative joint symptoms: a risk factor for pouchitis in ulcerative colitis patients. Dig Surg 2006;23:60-4. [PMID: 16717470 DOI: 10.1159/000093495] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
221 Ono K, Kishimoto M, Deshpande GA, Fukui S, Kawaai S, Sawada H, Matsuura M, Rodriguez VR, Proft F, Tada K, Tamura N, Taniguchi Y, Hirata A, Kameda H, Tsuji S, Kaneko Y, Dobashi H, Okano T, Haji Y, Morita A, Okada M, Komagata Y, Medina CL, Molto A, Dougados M, Hisamatsu T, Tomita T, Kaname S. Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis. Rheumatol Int. [DOI: 10.1007/s00296-022-05117-0] [Reference Citation Analysis]
222 Lakatos PL, Lakatos L, Kiss LS, Peyrin-biroulet L, Schoepfer A, Vavricka S. Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease. Digestion 2012;86:28-35. [DOI: 10.1159/000341950] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
223 Karreman MC, Luime JJ, Hazes JMW, Weel AEAM. The Prevalence and Incidence of Axial and Peripheral Spondyloarthritis in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. J Crohns Colitis. 2017;11:631-642. [PMID: 28453761 DOI: 10.1093/ecco-jcc/jjw199] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 6.5] [Reference Citation Analysis]
224 Garber A, Regueiro M. Extraintestinal Manifestations of Inflammatory Bowel Disease: Epidemiology, Etiopathogenesis, and Management. Curr Gastroenterol Rep. 2019;21:31. [PMID: 31098819 DOI: 10.1007/s11894-019-0698-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
225 Dallocchio A, Canioni D, Ruemmele F, Duquesne A, Scoazec J, Bouvier R, Paraf F, Languepin J, Wouters CH, Guillot M, Quartier P, Bader-meunier B; the SOFREMIP. Occurrence of inflammatory bowel disease during treatment of juvenile idiopathic arthritis with etanercept: a French retrospective study. Rheumatology 2010;49:1694-8. [DOI: 10.1093/rheumatology/keq136] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 3.2] [Reference Citation Analysis]
226 Turina MC, Landewé R, Baeten D. Lessons to be learned from serum biomarkers in psoriasis and IBD – the potential role in SpA. Expert Review of Clinical Immunology 2017;13:333-44. [DOI: 10.1080/1744666x.2017.1244004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
227 Walker DG, Williams HR, Kane SP, Mawdsley JE, Arnold J, McNeil I, Thomas HJ, Teare JP, Hart AL, Pitcher MC, Walters JR, Marshall SE, Orchard TR. Differences in inflammatory bowel disease phenotype between South Asians and Northern Europeans living in North West London, UK. Am J Gastroenterol. 2011;106:1281-1289. [PMID: 21577243 DOI: 10.1038/ajg.2011.85] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
228 Skendros P, Papagoras C, Mitroulis I, Ritis K. Autoinflammation: Lessons from the study of familial Mediterranean fever. J Autoimmun 2019;104:102305. [PMID: 31337526 DOI: 10.1016/j.jaut.2019.102305] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
229 Wang J, Wang X, Wu H, Sun H, Liu D, Zhang W, Jin C, Wang S. The association between pulmonary function impairment and colon inflammation in ulcerative colitis patients: A scientific basis for exterior-interior correlation between lung and large intestine. Chin J Integr Med 2016;22:894-901. [DOI: 10.1007/s11655-014-1842-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
230 Ott C, Schölmerich J. Extraintestinal manifestations and complications in IBD. Nat Rev Gastroenterol Hepatol. 2013;10:585-595. [PMID: 23835489 DOI: 10.1038/nrgastro.2013.117] [Cited by in Crossref: 124] [Cited by in F6Publishing: 115] [Article Influence: 13.8] [Reference Citation Analysis]
231 Shivashankar R, Loftus EV Jr, Tremaine WJ, Harmsen WS, Zinsmeister AR, Matteson EL. Incidence of Spondyloarthropathy in patients with ulcerative colitis: a population-based study. J Rheumatol 2013;40:1153-7. [PMID: 23678160 DOI: 10.3899/jrheum.121029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
232 Bourikas LA, Papadakis KA. Musculoskeletal manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 2009;15:1915-1924. [PMID: 19408334 DOI: 10.1002/ibd.20942] [Cited by in Crossref: 48] [Cited by in F6Publishing: 34] [Article Influence: 3.7] [Reference Citation Analysis]
233 González-Lama Y, Sanz J, Bastida G, Campos J, Ferreiro R, Joven B, Gutiérrez A, Juanola X, Sicilia B, Veroz R, P Gisbert J, Chaparro M, Domènech E, Esteve M, Gomollón F. Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritis. Gastroenterol Hepatol 2020;43:273-83. [PMID: 32247533 DOI: 10.1016/j.gastrohep.2020.01.005] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
234 Cantini F, Niccoli L, Nannini C, Cassarà E, Kaloudi O, Rizzello F, Gionchetti P. Case-control Study on Dactylitis, Enthesitis, and Anterior Uveitis in Spondyloarthritis Associated with Inflammatory Bowel Diseases: Role of Coexistent Psoriasis. J Rheumatol 2017;44:1341-6. [PMID: 28412702 DOI: 10.3899/jrheum.161518] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.2] [Reference Citation Analysis]
235 Tozun N, Atug O, Imeryuz N, Hamzaoglu HO, Tiftikci A, Parlak E, Dagli U, Ulker A, Hulagu S, Akpinar H. Clinical characteristics of inflammatory bowel disease in Turkey: a multicenter epidemiologic survey. J Clin Gastroenterol. 2009;43:51-57. [PMID: 18724251 DOI: 10.1097/mcg.0b013e3181574636] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.7] [Reference Citation Analysis]
236 Reinisch W, Miehsler W, Dejaco C, Harrer M, Waldhoer T, Lichtenberger C, Vogelsang H. An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia: ROFECOXIB IN IBD-ASSOCIATED PERIPHERAL ARTHRITIS AND ARTHRALGIA. Alimentary Pharmacology & Therapeutics 2003;17:1371-80. [DOI: 10.1046/j.1365-2036.2003.01596.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 2.8] [Reference Citation Analysis]
237 Wiens J, Rankin JA, Then KL. Arthropathies in Inflammatory Bowel Disease: A Review for Clinicians. Gastroenterol Nurs 2017;40:496-503. [PMID: 28727666 DOI: 10.1097/SGA.0000000000000175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
238 De Vos M. Joint involvement in inflammatory bowel disease: managing inflammation outside the digestive system. Expert Rev Gastroenterol Hepatol 2010;4:81-9. [PMID: 20136591 DOI: 10.1586/egh.09.75] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
239 Amarnani A, Thakker S, Panush RS. Reflecting on the immunopathology of arthritis associated with inflammatory bowel disease: what do we know and what should we know? Clin Rheumatol 2022. [PMID: 35543893 DOI: 10.1007/s10067-022-06201-3] [Reference Citation Analysis]
240 Walker DG, Williams HR, Bancil AS, Rai P, Pantelidis P, Chambers J, Kooner JS, Sato H, Orchard TR. Ethnicity differences in genetic susceptibility to ulcerative colitis: a comparison of Indian asians and white northern Europeans. Inflamm Bowel Dis. 2013;19:2888-2894. [PMID: 24145928 DOI: 10.1097/01.mib.0000437567.12067.e7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
241 Su CG, Judge TA, Lichtenstein GR. Extraintestinal manifestations of inflammatory bowel disease. Gastroenterol Clin North Am. 2002;31:307-327. [PMID: 12122740 DOI: 10.1016/s0889-8553(01)00019-x] [Cited by in Crossref: 130] [Cited by in F6Publishing: 42] [Article Influence: 6.5] [Reference Citation Analysis]
242 Jansson S, Malham M, Paerregaard A, Jakobsen C, Wewer V. Extraintestinal Manifestations Are Associated With Disease Severity in Pediatric Onset Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:40-5. [PMID: 32187141 DOI: 10.1097/MPG.0000000000002707] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
243 Karimi O, Peña AS. Indications and challenges of probiotics, prebiotics, and synbiotics in the management of arthralgias and spondyloarthropathies in inflammatory bowel disease. J Clin Gastroenterol 2008;42 Suppl 3 Pt 1:S136-41. [PMID: 18806706 DOI: 10.1097/MCG.0b013e3181662455] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
244 Luzoro A, Sabat P, Guzmán L, Frias F. Manifestaciones extraintestinales de enfermedad inflamatoria intestinal. Revista Médica Clínica Las Condes 2019;30:305-14. [DOI: 10.1016/j.rmclc.2019.06.001] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
245 Ahmad T, Armuzzi A, Bunce M, Mulcahy–hawes K, Marshall SE, Orchard TR, Crawshaw J, Large O, De Silva A, Cook JT, Barnardo M, Cullen S, Welsh KI, Jewell DP. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 2002;122:854-66. [DOI: 10.1053/gast.2002.32413] [Cited by in Crossref: 414] [Cited by in F6Publishing: 406] [Article Influence: 20.7] [Reference Citation Analysis]
246 Williams H, Walker D, Orchard TR. Extraintestinal manifestations of inflammatory bowel disease. Curr Gastroenterol Rep. 2008;10:597-605. [PMID: 19006617 DOI: 10.1007/s11894-008-0108-6] [Cited by in Crossref: 50] [Cited by in F6Publishing: 50] [Article Influence: 3.8] [Reference Citation Analysis]
247 İlgen U, Emmungil H. Enteropathic Arthritis Beyond the Criteria. Inflamm Bowel Dis 2021:izab269. [PMID: 34757420 DOI: 10.1093/ibd/izab269] [Reference Citation Analysis]
248 Marques C, Kakehasi AM, Gomides APM, Paiva EDS, Dos Reis Neto ET, Pileggi GCS, Provenza JR, Mota L, Xavier RM, Ferreira GA, Pinheiro MM. A Brazilian Cohort of Patients With Immuno-Mediated Chronic Inflammatory Diseases Infected by SARS-CoV-2 (ReumaCoV-Brasil Registry): Protocol for a Prospective, Observational Study. JMIR Res Protoc 2020;9:e24357. [PMID: 33156812 DOI: 10.2196/24357] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
249 Caprilli R, Gassull MA, Escher JC, Moser G, Munkholm P, Forbes A, Hommes DW, Lochs H, Angelucci E, Cocco A, Vucelic B, Hildebrand H, Kolacek S, Riis L, Lukas M, de Franchis R, Hamilton M, Jantschek G, Michetti P, O'Morain C, Anwar MM, Freitas JL, Mouzas IA, Baert F, Mitchell R, Hawkey CJ; European Crohn's and Colitis Organisation. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 2006;55 Suppl 1:i36-58. [PMID: 16481630 DOI: 10.1136/gut.2005.081950c] [Cited by in Crossref: 311] [Cited by in F6Publishing: 255] [Article Influence: 19.4] [Reference Citation Analysis]
250 Vavricka SR, Brun L, Ballabeni P, Pittet V, Prinz Vavricka BM, Zeitz J, Rogler G, Schoepfer AM. Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol. 2011;106:110-119. [PMID: 20808297 DOI: 10.1038/ajg.2010.343] [Cited by in Crossref: 265] [Cited by in F6Publishing: 225] [Article Influence: 22.1] [Reference Citation Analysis]
251 Vayssade M, Tatar Z, Soubrier M. Rhumatisme palindromique. La Revue de Médecine Interne 2013;34:47-52. [DOI: 10.1016/j.revmed.2012.07.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
252 Mazzei MA, Gentili F, Guerrini S, Di Meglio N, Lo Re G, Carotti M, Interlicchia F, Reginelli A, Barile A, Sadotti G, Plastina Romeo U, La Paglia E, Maggialetti N, Lo Scalzo R, Vinci A, Capodieci G, Vacca G, Bruno F, Cantarini L, Frediani B, Marchesoni A, Giovagnoni A, Volterrani L, Brunese L. Inflammatory Bowel Diseases and Coexisting Spondyloarthritis: A Neglected and too Often Under-Reported Association by Radiologists. A Multicenter Study by Italian Research Group of Imaging in Rheumatology. Gastroenterology Insights 2020;11:47-57. [DOI: 10.3390/gastroent11020008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
253 Schirbel A, Reichert A, Roll S, Baumgart DC, Büning C, Wittig B, Wiedenmann B, Dignass A, Sturm A. Impact of pain on health-related quality of life in patients with inflammatory bowel disease. World J Gastroenterol 2010; 16(25): 3168-3177 [PMID: 20593502 DOI: 10.3748/wjg.v16.i25.3168] [Cited by in CrossRef: 77] [Cited by in F6Publishing: 71] [Article Influence: 6.4] [Reference Citation Analysis]
254 Jung HI, Kim HJ, Kim JM, Lee JY, Park KS, Cho KB, Lee YJ. Co-existence of relapsing polychondritis and Crohn disease treated successfully with infliximab. Yeungnam Univ J Med 2021;38:70-3. [PMID: 32668525 DOI: 10.12701/yujm.2020.00304] [Reference Citation Analysis]
255 Manasson J, Scher JU. Spondyloarthritis and the microbiome: new insights from an ancient hypothesis. Curr Rheumatol Rep 2015;17:10. [PMID: 25663180 DOI: 10.1007/s11926-014-0487-7] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
256 Marín-Jiménez I, Gisbert JP, Pérez-Calle JL, García-Sánchez V, Tabernero S, García-Vicuña R, Romero C, Juliá B, Vanaclocha F, Cea-Calvo L; Investigadores del estudio AQUILES. [Two-year incidence of new immune-mediated inflammatory diseases in patients with inflammatory bowel disease: A study in the AQUILES cohort]. Gastroenterol Hepatol 2015;38:569-74. [PMID: 25983283 DOI: 10.1016/j.gastrohep.2015.04.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
257 Singh B, Kedia S, Konijeti G, Mouli VP, Dhingra R, Kurrey L, Srivastava S, Pradhan R, Makharia G, Ahuja V. Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: Frequency and relation with disease phenotype. Indian J Gastroenterol. 2015;34:43-50. [PMID: 25663290 DOI: 10.1007/s12664-015-0538-7] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
258 Thjodleifsson B, Geirsson AJ, Björnsson S, Bjarnason I. A common genetic background for inflammatory bowel disease and ankylosing spondylitis: a genealogic study in Iceland. Arthritis Rheum 2007;56:2633-9. [PMID: 17665420 DOI: 10.1002/art.22812] [Cited by in Crossref: 61] [Cited by in F6Publishing: 56] [Article Influence: 4.1] [Reference Citation Analysis]
259 Nir O, Rinawi F, Amarilyo G, Harel L, Shamir R, Assa A. Phenotypic Features and Longterm Outcomes of Pediatric Inflammatory Bowel Disease Patients with Arthritis and Arthralgia. J Rheumatol 2017;44:1636-43. [PMID: 28864649 DOI: 10.3899/jrheum.170168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
260 Fleisher M, Marsal J, Lee SD, Frado LE, Parian A, Korelitz BI, Feagan BG. Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease. Dig Dis Sci 2018;63:825-33. [PMID: 29484571 DOI: 10.1007/s10620-018-4971-1] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
261 Biancone L, Michetti P, Travis S, Escher JC, Moser G, Forbes A, Hoffmann JC, Dignass A, Gionchetti P, Jantschek G, Kiesslich R, Kolacek S, Mitchell R, Panes J, Soderholm J, Vucelic B, Stange E. European evidence-based Consensus on the management of ulcerative colitis: Special situations. Journal of Crohn's and Colitis 2008;2:63-92. [DOI: 10.1016/j.crohns.2007.12.001] [Cited by in Crossref: 168] [Cited by in F6Publishing: 127] [Article Influence: 12.0] [Reference Citation Analysis]
262 Rinawi F, Zevit N, Eliakim R, Niv Y, Shamir R, Assa A. Long-Term Outcomes After Primary Bowel Resection in Pediatric-Onset Crohn's Disease. Inflamm Bowel Dis 2017;24:149-58. [PMID: 29272491 DOI: 10.1093/ibd/izx030] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]